Dashboard
Poor Management Efficiency with a low ROCE of 9.35%
- The company has been able to generate a Return on Capital Employed (avg) of 9.35% signifying low profitability per unit of total capital (equity and debt)
Low ability to service debt as the company has a high Debt to EBITDA ratio of 1.87 times
The company has declared Positive results for the last 4 consecutive quarters
With ROE of 4.14%, it has a very expensive valuation with a 1.34 Price to Book Value
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
Spire Healthcare Group Plc for the last several years.
Risk Adjusted Returns v/s 
News

Spire Healthcare Stock Hits Day Low of GBP 1.79 Amid Price Pressure
Spire Healthcare Group Plc faced notable stock volatility, hitting an intraday low and experiencing a significant decline in its stock price. The company reported a low Return on Capital Employed and a concerning Debt to EBITDA ratio, despite positive operating cash flow and net sales over the past four quarters.
Read More
Spire Healthcare Group Plc Hits Day Low of GBP 1.85 Amid Price Pressure
Spire Healthcare Group Plc has faced notable stock volatility, hitting an intraday low and experiencing significant declines over various timeframes. Despite reporting positive quarterly results, the company struggles with low return on equity and a high debt-to-EBITDA ratio, reflecting ongoing financial challenges. Its market capitalization is GBP 748 million.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot
Shareholding Compare (%holding) 
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 11.20% vs 13.39% in Dec 2023
YoY Growth in year ended Dec 2024 is -6.81% vs 240.24% in Dec 2023






